Financhill
Back

Chemomab Therapeutics Quote, Financials, Valuation and Earnings

Sell
50

CMMB
Chemomab Therapeutics

Last Price:
0.87
Seasonality Move:
-7.77%

7 Day Trial

ALL ACCESS PASS

$ 7

Chemomab Therapeutics Price Quote

$0.87
+0.03 (+0%)
(Updated: May 18, 2024 at 5:39 AM ET)

Chemomab Therapeutics Key Stats

Sell
50
Chemomab Therapeutics (CMMB) is a Sell

Day range:
$0.83 - $0.88
52-week range:
$0.42 - $1.89
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.9%

Volume:
53.8K
Avg. volume:
103.4K
1-year change:
-53.28%
Market cap:
$12M
Revenue:
$0
EPS:
$-2.52

How Much Does Chemomab Therapeutics Make?

Data Unavailable

Is Chemomab Therapeutics Growing As A Company?

Data Unavailable

Chemomab Therapeutics Stock Price Performance

What Is Chemomab Therapeutics 52-Week High & Low?

Chemomab Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Chemomab Therapeutics?

Is Chemomab Therapeutics Cash Flow Positive?

Data Unavailable

Chemomab Therapeutics Return On Invested Capital

Data Unavailable

Chemomab Therapeutics Earnings Date & Stock Price

Chemomab Therapeutics Competitors

Chemomab Therapeutics Dividend Yield

Data Unavailable

Chemomab Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 6.67%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 6.50
Upside from Last Price: 672.89%

Major Shareholders

  • How many CMMB shares are owned by institutional investors?
    2.8M CMMB shares are owned by institutional investors
  • How many CMMB shares are owned by insiders?
    339.4K CMMB shares are owned by insiders